Analysis of the function of TM4SF complex and lung cancer gene therapy based on using this complex.
Analysis of the function of TM4SF complex and lung cancer gene therapy based on using this complex.
批准号:
14370421
负责人:
MIYAKE Masayuki
金额:
$9.02万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
2002
资助国家:
日本
项目状态:
已结题
起止时间:
2002 至 2003
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Establishment of cell lines in each stage plays a most important role to clarify abnormality of the TM4SF complex. Previously, we reported mixing 50% matrigel in this collagen is the most efficient for establishment of the cell lines. Adding 10% of patients' serum in the above mixture made it easier to establish the cell line. Using this method, three kinds of AAH were established. There were no abnormality in the expression of MRP-1/CD9、KAI1/CD82 in these cell lines. And also PETA3/CD15I expression appeared decreasing. Next, 10 cell lines were established in Stage I lung cancer, 9 cell lines were established in Stage II lung cancer. We tried to establish 13 cell lines in Stage III lung cancer that did chemotherapy before the operation, however only 4 cell lines were established because most of the parts were necrotic region. Six kinds of cell lines in StageIV were established from the specimens of metastasis region. Then, the complex formation of MRP-1/CD9、KAI1/CD82 and PETA3/CD 151 were analyzed. In the Stage I, MRP-1/CD9 and KAI1/CD82 expression were found in two cell lines except one, but PETA3/CDI5I appeared weak expression. In the Stage II, KAI1/CD82 was decreasing in 5 cases and MRP-1/CD9 was decreasing in I. case, however PETA3/CD151 was increasing in 2 cases. In the StageIII, only KAII/CD82was found decreasing in 4 cases. Then only PETA3/CD151 was appeared in the last 1case. In the StageIV、 expression of PETA3/CD151 was positive in almost all metastatic cell lines. From these experiments, MRP-1/CD9 and KAI1/CD82 play an important role as metastasis suppressor genes. On the other hand, PETA3/CD151 plays a metastasis promotion gene. Hence, the balance and unbalance of these expressions have something to do with the process of metastasis.
期刊论文(64)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
三宅正幸: "肺癌の生物学的予後因子"呼吸器疾患を探る-腫瘍編-. 22-26 (2003)
Masayuki Miyake:“肺癌的生物学预后因素”探索呼吸系统疾病 - 肿瘤版 - 22-26 (2003)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Shimizu, K., Chin, K., Nakamura, T., Masuzaki, H., Ogawa, Y., Hosokawa, R., Niimi, A., Hattori, N., Sasayama, S., Nakao, K., Mishima, M., Nakamura, T., Ohi, M.: "Plasma leptin levels and cardiac sympathetic function in patients with obstructive sleep apno
清水 K.、钦 K.、中村 T.、增崎 H.、小川 Y.、细川 R.、新美 A.、服部 N.、筱山 S.、中尾 K.、
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Hashida, H., Takabayashi, A., Kanai, M., Adachi, M., Kondo, K., Kohno, N., Yamaoka, Y., Miyake, M.: "Aminopeptidase N Is Involved in Cell Motility and Angiogenesis : Its Clinical Significance in Human Colon Cancer."GASTRORNTEROLOGY. 122. 376-386 (2002)
Hashida, H.、Takabayashi, A.、Kanai, M.、Adachi, M.、Kondo, K.、Kohno, N.、Yamaoka, Y.、Miyake, M.:“氨基肽酶 N 参与细胞运动和血管生成
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Hattori, N., Mizuno, S., Yoshida, Y, Chin, K., Mishima, M., Sisson, TH., Simon, RH., Nakamura, T., Miyake, M.: "The Plasminogen activation system reduces fibrosis in the lung by a Hepatocyte growth factor-dependent mechanism."AM J PATHOL. 164. 1091-1098 (
Hattori, N.、Mizuno, S.、Yoshida, Y、Chin, K.、Mishima, M.、Sisson, TH.、Simon, RH.、Nakamura, T.、Miyake, M.:“纤溶酶原激活系统可减少
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Kohno, M., et al.: "CD151 enhances cell motility and metastasis of cancer cells in the presence of focal adhesion kinase"International Journal of Cancer. 97. 336-343 (2002)
Kohno, M., 等人:“CD151 在粘着斑激酶存在下增强癌细胞的细胞运动和转移”国际癌症杂志。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 28 条
Inhibition of metastasis and tetraspanin expression by the human monoclonal antibody directed to CD151 and RNA interference
-
批准号:19390369
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$12.23万
-
财政年份:2007
-
负责人:MIYAKE Masayuki
-
依托单位:
Analysis of the function of TM4SF complex and its application of lung cancer therapy.
-
批准号:16390400
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$8.0万
-
财政年份:2004
-
负责人:MIYAKE Masayuki
-
依托单位:
Suppression of metastasis due to regulation of PETA3/CD151
-
批准号:12470280
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$9.41万
-
财政年份:2000
-
负责人:MIYAKE Masayuki
-
依托单位:
Cancer Gene Therapy with Adenovirally or Immunogene TM4SF
-
批准号:10557115
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$8.0万
-
财政年份:1998
-
负责人:MIYAKE Masayuki
-
依托单位:
The analysis of the function of TM4SF and the suppression of the cancer metastasis by its regulation
-
批准号:08407040
-
项目类别:Grant-in-Aid for Scientific Research (A)
-
资助金额:$25.92万
-
财政年份:1996
-
负责人:MIYAKE Masayuki
-
依托单位:
Prospective study of the patients with cancer according to MRP-1/CD9 status and regulation of metastastasis of cancer by means of MRP-1/CD9 control
-
批准号:07557253
-
项目类别:Grant-in-Aid for Scientific Research (A)
-
资助金额:$4.42万
-
财政年份:1995
-
负责人:MIYAKE Masayuki
-
依托单位:
Analysis of structure of MRP-1/CD9 mutation and regulation of metastasis of cancer by means of MRP-1/CD9 control
-
批准号:06454405
-
项目类别:Grant-in-Aid for General Scientific Research (B)
-
资助金额:$4.1万
-
财政年份:1994
-
负责人:MIYAKE Masayuki
-
依托单位:
国内基金
海外基金
AAH羟化酶活性介导肝内胆管癌的经淋巴途径转移及分子机制
-
批准号:81772531
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2017
-
负责人:李俊
-
依托单位: